Springbok Capital Management »

Entrada Therapeutics shares owned by Springbok Capital Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $149k 26k 5.80